DM determines the cryptic and immunodominant fate of T cell epitopes

Journal of Experimental Medicine

Volumn 192, Issue 6, 2000, Pages 781-788

  Nanda, Navreet K ^a,c   Sant, Andrea J ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c Department of Microbiology and Immunology ^*  (United States)

Author keywords

Antigen determinant; Antigen processing; H 2M; Immunodominance; Major histocompatibility complex class II

Indexed keywords

EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HEN; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; WESTERN BLOTTING;

ANIMALS; DIMERIZATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HYBRIDOMAS; IMMUNITY, CELLULAR; IMMUNODOMINANT EPITOPES; L CELLS (CELL LINE); MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED STRAINS; MURAMIDASE; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; T-LYMPHOCYTES; TRANSFECTION;

EID: 0033807322     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.192.6.781     Document Type: Article

References (43)

1. Dominance and crypticity of T cell antigenic determinants
2. T cell determinant structure: Cores and determinant envelopes in three mouse major histocompatibility complex haplotypes
3. Heterogeneity of the T cell response to immunodominant determinants within hen eggwhite lysozyme of individual syngeneic hybrid F1 mice: Implications for autoimmunity and infection
4. Determinant selection for T-cell tolerance in HEL-transgenic mice: Dissociation between immunogenicity and tolerogenicity
5. How can cryptic epitopes trigger autoimmunity?
6. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses
7. How MHC molecules acquire peptide cargo: Biosynthesis and trafficking through the endocytic pathway
8. Assembly, transport, and function of MHC class II molecules
9. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3
10. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading
11. Mediation by HLA-DM of dissociation of peptides from HLA-DR
12. The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class-II molecules
13. A lysosomal targeting signal in the cytoplasmic tail of the β chain directs HLA-DM to MHC class II compartments
14. Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules
15. Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs
16. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM
17. Editing of the HLA-DR-peptide repertoire by HLA-DM
18. DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II molecules
19. The inability of the NOD class II molecule to form stable peptide complexes does not reflect a failure to interact productively with DM
20. Ia invariant chain detected on lymphocyte surfaces by a monoclonal antibody
21. Hybridoma cells secreting monoclonal antibodies to mouse H-2 and Ia antigens
22. Limitations in plasticity of the T-cell receptor repertoire
23. A truncated T cell receptor repertoire reveals underlying immunogenicity of an antigenic determinant
24. T cell clones to two major T cell epitopes of myoglobin: Effect of I-A/I-E restriction on epitope dominance
25. Production of T-T hybrids from T cell clones. Direct comparison between cloned T cells and T hybridoma cells derived from them
26. A unique pattern of lymphokine synthesis is a characteristic of certain antigen-specific suppressor T cell clones
27. Functionality of major histocompatibility complex class II molecules in mice doubly deficient for invariant chain and H-2M complexes
28. The cognitive paradigm and the immunological homunculus
29. Altered ligands reveal limited plasticity in the T cell response to a pathogenic epitope
30. TH1 and TH2 cell antigen receptors in experimental leishmaniasis
31. Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease
32. In vivo priming of T cells against cryptic determinants by dendritic cells exposed to interleukin 6 and native antigen
33. The involvement of antigen processing in determinant selection by class II MHC and its relationship to immunodominance
34. Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: Studies in the hen egg-white lysozyme (HEL) model
35. The role of H-2O and HLA-DO in major histocompatibility complex class-II-restricted antigen processing and presentation
36. Negative regulation by HLA-DO of MHC class II-restricted antigen processing
37. Regulation of antigen presentation by acidic pH
38. pH dependence and exchange of high and low responder peptides binding to a class-II MHC molecules
39. Functional HLA-DM on the surface of B cells and immature dendritic cells
40. HLA-DM and the MHC class II antigen presentation pathway
41. Mapping T-cell receptor peptide contacts by variant peptide immunization of single chain transgenics
42. Induction of anti-self-immunity to cure cancer
43. Recognition of prostate-specific antigenic peptide determinants by human CD4 and CD8 T cells